Merck & Co (NYSE: MRK)
DRUGS - Drug Manufacturers - MajorSector: Health Care
Stock price data as of 02/07/2025
Closing price: 87.28
Support price level: | N/A |
Resistance price level: | $96.01 |
Relative strength index (14-day RSI) | 26.1 |
Beta | 0.01 |
- MRK is at or near its 52-week low. Though contrarian gains may be possible, the risk of further declines is considerable.
- With a -31.2 percent return in the past year, this stock is among the worst 10 percent of performers in the S&P-100.
- MRK is one of this month's worst performers with a return of -12.6%, underperforming 90 percent of stocks in the S&P-100.
- Down 11.7 percent, MRK is one of this week's biggest decliners.
- The price of this low-beta stock is expected to increase by 0.01% for every 1% increase in the S&P-500.
- Volatility is forecast to fall over the next month.
- With RSI < 30, MRK is oversold. Odds slightly favor a short-term price reversal.
- Price broke below prior support level - a short-term bearish signal.
Low | High | Price as % of Range |
$87.28 | $132.96 | 0.0% |
200 day | 50 day | 20 day | 10 day |
$113.56 | $98.93 | $96.48 | $94.70 |
Historical (5 year) |
Last month | Current estimate | Next month forecast |
23.8% | 20.5% | 38.0% | 29.5% |
- 10.3% in the next week.
- 16.7% in the next month.
- 44.7% in the next year.
Company news for Merck & Co
Google Finance |
MarketWatch |
WSJ
Analysis for other Health Care stocks